Inventor · disambiguated record
Hirotake Mizutani
Also filed as: MIZUTANI HIROTAKE
14 granted patents·7 pending applications·84 citations·filing 2007–2024
92Inventor score
Files withMILLENNIUM PHARM INC13TAKEDA PHARMACEUTICALS CO4ARMITAGE Ian1CIAVARRI JEFFREY1CLAIBORNE CHRISTOPHER F1
Top patents by PatentIndex Score
21 records- 0197US8008307B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2007·Granted Aug 30, 2011·25 cites·17 claims
- 0295US8481550B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesCLAIBORNE CHRISTOPHER F·Filed 2011·Granted Jul 9, 2013·19 cites·14 claims
- 0394US9150525B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2014·Granted Oct 6, 2015·10 cites·19 claims
- 0488US9962386B2Heteroaryl compounds useful as inhibitors of SUMO activating enzymeMILLENNIUM PHARM INC·Filed 2017·Granted May 8, 2018·6 cites·39 claims
- 0588US9458108B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2015·Granted Oct 4, 2016·3 cites·18 claims
- 0687US9683003B2Heteroaryl compounds useful as inhibitors of SUMO activating enzymeMILLENNIUM PHARM INC·Filed 2015·Granted Jun 20, 2017·7 cites·55 claims
- 0786US10335410B2Heteroaryl compounds useful as inhibitors of sumo activating enzymeMILLENNIUM PHARM INC·Filed 2018·Granted Jul 2, 2019·4 cites·14 claims
- 0885US10780090B2Heteroaryl compounds useful as inhibitors of SUMO activating enzymeMILLENNIUM PHARM INC·Filed 2019·Granted Sep 22, 2020·1 cites·16 claims
- 0980US2023293522A1Heteroaryl compounds useful as inhibitors of sumo activating enzymeTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1079US11542293B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 3, 2023·1 cites·23 claims
- 1177US9695154B2Heteroaryl inhibitors of sumo activating enzymeMILLENNIUM PHARM INC·Filed 2014·Granted Jul 4, 2017·4 cites·34 claims
- 1276US2025262298A1Sting modulator compounds with sulfamate linkages, and methods of making and usingCIAVARRI JEFFREY·Filed 2024·Application pending·0 cites
- 1374US8933225B2Process for the synthesis of E1 activating enzyme inhibitorsARMITAGE Ian·Filed 2008·Granted Jan 13, 2015·2 cites·14 claims
- 1472US2022331316A1Heteroaryl compounds useful as inhibitors of sumo activating enzymeMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 1570US12054512B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Aug 6, 2024·0 cites·23 claims
- 1669US9139589B2Heteroaryls and uses thereofHIROSE MASAAKI·Filed 2010·Granted Sep 22, 2015·2 cites·28 claims
- 1767US9718788B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2016·Granted Aug 1, 2017·0 cites·1 claims
- 1867US2010197924A1Preparation of aminotetralin compoundsMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 1962US2015112071A1Preparation of aminotetralin compoundsMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2061US2021015915A1Sting modulator compounds with sulfamate linkages, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 2160US2014256947A1Preparation of aminotetralin compoundsMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →